CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Photodynamic therapy

Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy.

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy.

Abstract Source:

Curr Clin Pharmacol. 2006 Sep;1(3):217-22. PMID: 18666746

Abstract Author(s):

Malini Olivo, Hong-Yan Du, Boon-Huat Bay

Abstract:

Photodynamic therapy (PDT) involves the administration of a photosensitizer followed by light irradiation with a specific wavelength, giving rise to irreversible tissue destruction. Hypericin, a herbal extract derived from Hypericum perforatum or St. John's Wort, has minimal toxicity but exhibits potent photo-damaging effects in the presence of light. Hypericin is known to generate a high yield of singlet oxygen and other reactive oxygen species that are associated with photo-oxidative cellular damage. The application of PDT with hypericin for the treatment of cancers such as recurrent mesothelioma and skin cancer has been validated in clinical trials. This mini-review focuses on the investigative studies of hypericin as a potential photodynamic agent in the treatment of nasopharyngeal cancer (NPC) in in vitro and in vivo models. NPC is an enigmatic tumor with a multifactorial etiology and a high incidence in the populations of Southern China.

 
 

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.